Salmonella typhimurium strain TM677 was mutagenized with aflatoxin B1 (AFB1) in liquid suspension culture in the presence of a rat liver postmitochondrial supernatant. Forward mutation to 8-azaguanine resistance was measured in the treated cultures and was found to increase linearly with AFB1 concentration. DNA purified from mutagenized cells was analyzed for AFB1 adduct formation by high-pressure liquid chromatography after adduct liberation.
Aflatoxin B1 (AFB1) is one of the most potent liver toxins and carcinogens known (1) , and it is also an extraordinarily powerful mutagen in bacterial cells after mammalian metabolic activation (1) . Activated AFB1 is capable of binding to macromolecular cell constituents, and, in animals, the extent of binding differs as a function of organ and species (2), with the specific binding level generally decreasing in the order DNA, RNA, protein (2) . Although the specific involvement of any macromolecule as the critical target for carcinogenicity or mutagenicity has not been proved, most hypotheses implicate DNA because of its central role as the cellular repository of genetic information.
Results from several laboratories have indicated the importance of an electrophilic epoxide of AFB1 as the principal metabolite responsible for DNA binding in vitro and in vivo (2) (3) (4) (5) (6) (7) . It has been suggested that the epoxide is the ultimately carcinogenic metabolite of AFB1 (2, 3) , and, in all systems evaluated, the major DNA adduct is 2,3-dihydro-2-(N7-guanyl)-3-hydroxyaflatoxin B1 (AFBI-N7-Gua).
This laboratory is engaged in two related lines of investigation represented in this report on AFB1 mutagenesis in Salmonella typhimurium. Our program has the dual objectives of (i) characterization and quantitation of specific molecular lesions that result when carcinogenic and mutagenic chemicals are metabolized in the presence of nucleic acids in vitro and in vdvo (5, 6) and (ii) relating these molecular alterations to findings in quantitative mutation assays that accurately reflect the mutagenic potency of chemical compounds. The present project had the specific purpose of determining the quantitative relationship between the binding of AFB1 to Salmonella DNA, in the form of specific adducts and observed mutation to 8-azaguanine resistance (8AGR).
MATERIALS AND METHODS Bacterial Strains. S. typhimurium strain TM677 used in this study, is a histidine-prototrophic revertant of S. typhimurium strain TA1535 into which the R factor plasmid, pKM101, was inserted (8) . Bacteria were grown in Vogel-Bonner medium (9) to a cell density of approximately 85 Klett units (660-nm filter) and frozen at -80'C in 50-ml aliquots containing 10% (vol/vol) dimethyl sulfoxide.
Preparation of Cell Suspension. Fifty milliliters of frozen stock cells was thawed and diluted into 150 ml of minimal medium containing glucose (20 mg/ml), Casamino acids (2.0 mg/ml), biotin (2.24 ,g/ml), and ampicillin (30 Ag/ml). Cultures were grown by shaking at 130-150 rpm in four 500-ml flasks at 370C for 250-280 min until there was an increase of 230 Klett units (660-nm filter). At that point, the cultures were immediately added to the mutagenesis reaction mixtures.
Mutagenesis Assay. The procedure used was a modification of the 8AGR assay in S. typhimurium developed by Skopek et al. (8) . The reaction mixtures for mutagenesis contained 83 mM Hepes (pH 7.4),27.5 mM KCI, 6.4 mM MgCI2,1.2 mM NADP, 4.1 mM glucose 6-phosphate, 100 mM glucose, 83,l of rat liver 9000 X g supernatant per ml [prepared from sodium phenobarbital-treated rats (10)], 250,l of cell suspension per ml, and [3H]AFB1 [10 Ci/mmol (1 Ci = 3.7 X 1010 becquerels)] delivered to the reaction mixture in methanol (final methanol concentration, 0.3%).
The mutagenesis procedure was started by the addition of [3H]AFB1 solution to the reaction mixture, both freshly prepared. The mixtures were shaken in the dark at 70-80 rpm at 37°C for 35 min. At that point, samples were withdrawn from each flask for the assay of induction of 8AGR mutants and for counts of viable cells. The plating procedure was similar to the one describd (8) .
These reaction conditions for assaying mutation to 8AGR differ from those described (8) . The 8AGR forward mutation assay in Salmonella as originally described involved small reaction volumes (up to 5 ml) and low cell concentrations (2.5 X 106 to 1 X 107 cells per ml). With a DNA content of 11 fg per Salmonella cell (11), a typical 5- (AFB,-dihydrodiol) from AFBI-N7-Gua (7) . For this analysis, the column was eluted with 25% ethanol containing 0.001% acetic acid at 1 ml/min. RESULTS AFB1 Mutagenesis. A linear relationship was obtained between the induced 8AGR fraction (observed fraction -control fraction) and the concentration of AFB1 (Fig. 1) . Virtually all cells survived the mutagenesis procedure even at the highest scribed that could dissociate the AFBI-DNA complex or alter the adduct structure were modified. The heating step (12) was omitted, the pH of the buffers was not higher than 6.8, and the isolation procedure was carried out in tungsten light or in the dark. Also, NaCI replaced NaCl04 in order to avoid possible oxidation of the adduct. Under the conditions used, 2.57 mg of DNA was isolated from cultures treated with 0.16 MM AFB1 (designated DNA1) and 1.85 mg from those treated with 0.32 MM (designated DNA2). These preparations contained no detectable RNA and less than 150 Mg of protein. The efficiency of DNA extraction was 80-90%. (Total DNA content of the cultures was determined in samples that were lysed and treated as described above except that DNA was not isolated from them. They were deproteinized by treatment with 0.5 M HC104, and DNA was assayed by UV absorbance at 260 nm and by the diphenylamine color reaction.)
Because AFBI-adducted DNA had not been isolated previously from bacteria, it was necessary to determine the stability of the [3H]AFBI-DNA adduct during the various steps of cell lysis and DNA isolation. Heavily adducted calf thymus DNA (1 [3H]AFB1 residue per 200 nucleotides) was subjected to the entire procedure of cell lysis by Sarkosyl, lysozyme, RNase, and Pronase treatment and DNA purification, and 84% of the original specific radioactivity was retained. We assume that DNA modified to a lesser extent would retain at least the same fraction of AFB1 residues bound to DNA as observed here. Of the radioactivity taken up by Salmonella cells, 1 The principal aflatoxin-DNA adduct identified in the Salmonella DNA was AFBI-N7-Gua. Seventy percent of the radioactivity incorporated into each DNA sample eluted at the retention time of this adduct under two sets of chromatographic conditions (Fig. 2) . The remaining radioactivity (peak III in Fig.  2) , representing approximately 30% of the AFB1 bound to DNA, remains unidentified, although it is possible that this peak contains polar AFBI-deoxyribonucleotide derivatives (20) . Neither the aflatoxin dihydrodiol nor the product tentatively identified (7) as the imidazole ring-opened derivative of the AFBI-N7-guanine adduct (peak II in Fig. 2 ) were observed in significant quantities. In our hands, the dihydrodiol is produced mainly by acidic treatment of AFB1-RNA or of AFB1-DNA that has been exposed previously to an alkaline pH [i.e., the dihydrodiol may be a facile hydrolysis product of the putative imidazole ring-opening product, 2,3-dihydro-2-(N5-formyl-2',5',6'-triamino-4-oxo-N5-pyrimidyl)- total extent of DNA modification by AFB1 seems to parallel species or organ susceptibility to tumor formation (2, 4, 5) . A noteworthy similarity between the present results and those produced previously in vitro (5, 7, 20) and in vivo (6, 7) is the fact that the major adduct between AFB1 and Salmonella DNA was AFBI-N7-Gua. Our earlier findings showed that this product resulted from reaction of the electron-deficient C-2 of the (3-(or exo-) epoxide of AFB1 with the nucleophilic N-7 atom of guanine, which resides in a sterically accessible position in the major groove of DNA (5) . Assuming that covalently bound AFB1 somehow initiates the mutagenic process, our present data may provide a first approximation of the efficiency by which covalently bound AFB1 induces mutation in Salmonella. The accuracy of this estimate is dependent upon two factors which are described in detail below.
The first factor relates to our estimation of the fraction of induced mutations detected in a forward mutation assay. AFB1 induces both base-pair substitution mutation and frameshift mutation in strains of Salmonella carrying the R-factor plasmid pKM101 (21, 22) . Under the conditions used in our studies, approximately 9-fold more revertants are induced in the base-pair substitution strain TA100 than in the frameshift strain TA98 on the Ames His+ reversion assay (21) . Although one might conclude from these data that AFB1 induces 9-fold more base-pair substitution mutations than frameshifts, it must be kept in mind that the efficiency with which AFB1 reacts with the specific DNA sequences in TA98 and TA100 to cause reversion may not be representative of the efficiency with which it reacts with other DNA sequences. For the arguments presented below, it is sufficient to conclude that AFB1 is capable of inducing both base-pair substitution and frameshift mutations in TM677, although the relative frequency with which they occur is not known.
From a theoretical point of view, it would not be expected that all base-pair substitution mutations induced by AFB1 would be observed as a phenotypic change in a forward mutation assay. Due to the degeneracy of the genetic code, it can be calculated that approximately 25% of all base-pair substitution mutations will not lead to an altered amino acid sequence in a protein (i.e., most mutations in the third base of a codon and many in the second base will not change the amino acid encoded by the original codon). Of the remaining base-pair substitution mutations that do alter amino acid sequence, some fraction of these will insert an incorrect amino acid and still give rise to a functional protein. This phenomenon has been observed by Yanofsky et al. (23) in the trpA gene in Escherichia coli. Because at present there is no way to estimate this fraction of cryptic mutations, it is assumed for the sake of argument that any mutation that inserts an incorrect amino acid of the same charge as the original may result in a functional or partially functional protein and, therefore, may not be phenotypically expressed. Considering all of the possible single-step mutations in the genetic code, it can be calculated that this class constitutes approximately 40% of the theoretically possible number of base-pair substitution mutations.
With the above theoretical points taken into consideration, it is reasonable to expect that as few as 35% of all base-pair substitution mutations induced by AFB1 would be observed as a phenotypic change in a forward mutation assay (25% of the base-substitution mutations may result in no amino acid change and 40% may insert an amino acid that still results in a functional protein). We assume that most frameshift mutations induced by AFB1 will be expressed in a forward mutation assay because these lesions inactivate large portions of the gene in which they occur. However, it could be postulated that some frameshifts occurring near the terminus of the gene may still allow the production of a functional gene product. Also, additions and deletions of nucleotides in multiples of three will add or delete amino acids in a protein but will leave the reading frame in mRNA intact. This type of "frameshift" mutation may also give rise to a functional protein and go undetected in a forward mutation assay.
A second important point to be addressed in attempting to relate DNA binding to mutation is the estimation of the size of the genetic target of this mutation assay. Although not all of the mutant phenotypes conferring 8AGR are known at present, it is known (24, 25) (19) .
Preliminary results have shown that some of the mutants produced appear to overproduce purine bases, possibly as a consequence of deregulation of purine biosynthesis. These data would appear to support the suggestion that mutation at loci other than XPRT could also lead to the 8AGR trait (unpublished results).
AFB1 treatments at 0.16 and 0.32 ALM for 35 min produced 15 and 22 adducts per genome, respectively. This means that 18 X 10-3 [15(1.2 X 10-3)] adducts would be expected to fall by chance in the target for 8AGR at the 0.16 ,uM treatment and 26 X 10-3 adducts for the 0.32 ,uM treatment. When these levels are compared to the induced 8AGR fractions for the low and high AFBj treatments (0.49 X 10-3 and 0.96 X 10-3, respectively), the data suggest that 27-37 adducts gave rise to one observed mutation. Thus, any chemical adduct present in the gene would have a probability of 1/27 to 1/37 of giving rise to an observed mutational event. The actual efficiency of adducts as mutagenic lesions probably is somewhat higher because the arguments developed earlier suggested that the observed mutant fraction induced by AFBj may have given substantial underestimates of the total number of mutations induced. It should be kept in mind that this calculated number of adducts per mutation is based on an estimated DNA target size that could vary from the actual size by a factor of 2 or 3. In the absence of information on exact target size, we consider that a 2-or 3-fold range in the number of adducts per mutation gives a reasonable estimate of mutagenic efficiency of DNA binding by AFB1.
The apparent excess number of total adducts relative to the number of mutations induced is not surprising. This excess could result from a low mutation efficiency of some or all AFBI adducts or from the presence of a DNA repair process competing with the fixation of premutagenic lesions. The possibility also exists that quantitatively minor adducts, representing a small percentage of the total binding, are actually the precursors to mutation and act through a more highly efficient mechanism of mutation. The mutations induced could also be the result of an error-prone repair system acting on the adducted DNA.
The possibility cannot be ruled out that the mutagenic activity of AFB1 in Salmonella results from interactions with macromolecules other than DNA, especially in view of the fact
